FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / J Virol / A primary production deficit in the thrombocytopenia of equi...
Journal of virology1996; 70(11); 7842-7850; doi: 10.1128/JVI.70.11.7842-7850.1996

A primary production deficit in the thrombocytopenia of equine infectious anemia.

Abstract: The purpose of this study was to identify the mechanisms responsible for the thrombocytopenia that develops following infection of horses by the lentivirus equine infectious anemia virus (EIAV). Immunocompetent Arabian foals and Arabian foals with severe combined immunodeficiency (SCID), which lack functional B and T lymphocytes, were experimentally infected with EIAV. Levels of viremia and a number of clinical and hematologic parameters were examined prior to and following infection. Thrombocytopenia was not dependent on the immune response: SCID foals were affected as severely as immunocompetent foals. Production of platelets, measured by metabolic incorporation of radioactive label, was significantly reduced. The decrease ranged from 35 to 89% in three SCID and two immunocompetent foals examined. Platelet survival, measured by 51Cr labeling, also declined following infection in both SCID and immunocompetent foals: 51 and 68%, respectively, relative to the preinfection life spans. The difference between immunocompetent and immunodeficient foals was not statistically significant. The number of megakaryocytes (MK) per square millimeter of bone marrow, determined by digitizing morphometry, was not significantly altered in either SCID or immunocompetent thrombocytopenic foals. Numbers of denuded MK nuclei per unit area increased, but the elevation was not statistically significant. No evidence for viral replication in MK was found. Three different parameters of intravascular coagulation (activated prothombin time, fibrin degradation products, and one-step prothombin time) remained normal until after platelet numbers had declined significantly, arguing against an important role for disseminated intravascular coagulation. The findings indicate that EIAV induces thrombocytopenia principally through an indirect, noncytocidal suppressive effect on platelet production, the mechanism of which is unknown. A shortening of platelet life span apparently contributes moderately to the platelet deficit as well. The shortening of platelet life span is multifactorial in origin, including both mechanisms that depend on an active immune response and those that do not.
Get Full Text
Publication Date: 1996-11-01 PubMed ID: 8892906PubMed Central: PMC190855DOI: 10.1128/JVI.70.11.7842-7850.1996Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research study examines the decline in platelet production in horses after infection by the virus equine infectious anemia virus (EIAV). It concludes that the virus causes this decrease primarily through a non-lethal suppressive effect on platelet production rather than an active immune response.

Objectives of the Study

  • The aim of the research was to understand why there is a reduction in platelets (thrombocytopenia) after horses are infected by EIAV.

Methodology

  • Healthy Arabian foals and Arabian foals with severe combined immunodeficiency (SCID) – meaning they lack functional B and T lymphocytes – were infected with EIAV.
  • Levels of viremia and various clinical and hematologic parameters were measured before and after infection.
  • Platelet production was assessed by metabolic incorporation of radioactive label while platelet survival was evaluated using 51Cr labeling.
  • The number of megakaryocytes (MK), the platelet-forming cells in bone marrow, was determined via digitizing morphometry.
  • Different indicators of intravascular coagulation were also monitored.

Findings

  • The study found that thrombocytopenia was not dependent on the immune response as both SCID and healthy foals were affected to a similar degree.
  • Post-infection, platelet production was considerably decreased, ranging from a 35 to 89% reduction in different foals examined.
  • Moreover, platelet survival also fell following infection.
  • The number of MKs was not significantly altered, neither was the number of denuded MK nuclei per unit area.
  • No signs of viral replication in MKs were detected. Intravascular coagulation parameters remained normal until the drop in platelet numbers was significant, suggesting intravascular coagulation did not play a major role in the process.

Conclusion

  • The findings suggest that EIAV leads to thrombocytopenia mainly through a non-killing suppressive impact on platelet production. The reason behind this mechanism remains unknown.
  • A shortening of the platelet life span also contributes moderately to the reduction in platelets. This shortening is due to a variety of reasons, some of which depend on an active immune response and those that do not.

Cite This Article

APA
Crawford TB, Wardrop KJ, Tornquist SJ, Reilich E, Meyers KM, McGuire TC. (1996). A primary production deficit in the thrombocytopenia of equine infectious anemia. J Virol, 70(11), 7842-7850. https://doi.org/10.1128/JVI.70.11.7842-7850.1996

Publication

Journal of virology
ISSN: 0022-538X
NlmUniqueID: 0113724
Country: United States
Language: English
Volume: 70
Issue: 11
Pages: 7842-7850

Researcher Affiliations

Crawford, T B
  • Department of Veterinary Microbiology, Washington State University, Pullman 99164-7040, USA. crawford@vetmed.wsu.edu.
Wardrop, K J
    Tornquist, S J
      Reilich, E
        Meyers, K M
          McGuire, T C

            MeSH Terms

            • Animals
            • Antigens, Viral / analysis
            • Blood Coagulation Factors
            • Blood Platelets / physiology
            • Blood Platelets / ultrastructure
            • Bone Marrow Cells
            • Equidae
            • Equine Infectious Anemia / blood
            • Equine Infectious Anemia / physiopathology
            • Equine Infectious Anemia / virology
            • Infectious Anemia Virus, Equine / growth & development
            • Infectious Anemia Virus, Equine / immunology
            • Megakaryocytes / ultrastructure
            • Platelet Count
            • Severe Combined Immunodeficiency
            • Thrombocytopenia / physiopathology
            • Thrombocytopenia / veterinary
            • Viremia

            Grant Funding

            • 2-T32-AI07025 / NIAID NIH HHS
            • HL 46651 / NHLBI NIH HHS

            References

            This article includes 27 references
            1. Stephens RM, Casey JW, Rice NR. Equine infectious anemia virus gag and pol genes: relatedness to visna and AIDS virus.. Science 1986 Feb 7;231(4738):589-94.
              pubmed: 3003905doi: 10.1126/science.3003905google scholar: lookup
            2. McGuire TC, Henson JB, Quist SE. Impaired bone marrow response in equine infectious anemia.. Am J Vet Res 1969 Dec;30(12):2099-104.
              pubmed: 5389416
            3. Scadden DT, Zon LI, Groopman JE. Pathophysiology and management of HIV-associated hematologic disorders.. Blood 1989 Oct;74(5):1455-63.
              pubmed: 2676010
            4. Nieuwenhuis HK, Sixma JJ. Thrombocytopenia and the neglected megakaryocyte.. N Engl J Med 1992 Dec 17;327(25):1812-3.
              pubmed: 1435936doi: 10.1056/NEJM199212173272510google scholar: lookup
            5. Perryman LE, O'Rourke KI, McGuire TC. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection.. J Virol 1988 Aug;62(8):3073-6.
              pubmed: 2839723doi: 10.1128/JVI.62.8.3073-3076.1988google scholar: lookup
            6. O'Rourke K, Perryman LE, McGuire TC. Antiviral, anti-glycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus.. J Gen Virol 1988 Mar;69 ( Pt 3):667-74.
              pubmed: 3351480doi: 10.1099/0022-1317-69-3-667google scholar: lookup
            7. Hymes KB, Greene JB, Karpatkin S. The effect of azidothymidine on HIV-related thrombocytopenia.. N Engl J Med 1988 Feb 25;318(8):516-7.
              pubmed: 3422338doi: 10.1056/NEJM198802253180812google scholar: lookup
            8. Bull BS, Schneiderman MA, Brecher G. Platelet counts with the Coulter counter.. Am J Clin Pathol 1965 Dec;44(6):678-88.
              pubmed: 5846024doi: 10.1093/ajcp/44.6.678google scholar: lookup
            9. Nash RA, Burstein SA, Storb R, Yang W, Abrams K, Appelbaum FR, Boone T, Deeg HJ, Durack LD, Schuening FG. Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating platelets.. Blood 1995 Sep 1;86(5):1765-75.
              pubmed: 7655007
            10. Boudreaux MK, Weiss RC, Toivio-Kinnucan M, Spano JS. Potentiation of platelet responses in vitro by feline infectious peritonitis virus.. Vet Pathol 1990 Jul;27(4):261-8.
              pubmed: 2144930doi: 10.1177/030098589002700407google scholar: lookup
            11. Perryman LE, McGuire TC, Crawford TB. Maintenance of foals with combined immunodeficiency: causes and control of secondary infections.. Am J Vet Res 1978 Jun;39(6):1043-7.
              pubmed: 208432
            12. Issel CJ, Coggins L. Equine infectious anemia: current knowledge.. J Am Vet Med Assoc 1979 Apr 1;174(7):727-33.
              pubmed: 218920
            13. Zucker-Franklin D. The effect of viral infections on platelets and megakaryocytes.. Semin Hematol 1994 Oct;31(4):329-37.
              pubmed: 7831578
            14. DALTON AJ, LAW LW, MOLONEY JB, MANAKER RA. An electron microscopic study of a series of murine lymphoid neoplasms.. J Natl Cancer Inst 1961 Oct;27:747-91.
              pubmed: 13883254
            15. Karpatkin S, Nardi M, Lennette ET, Byrne B, Poiesz B. Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts.. Proc Natl Acad Sci U S A 1988 Dec;85(24):9763-7.
              pubmed: 3200854doi: 10.1073/pnas.85.24.9763google scholar: lookup
            16. Sentsui H, Kono Y. Complement-mediated hemolysis of horse erythrocytes treated with equine infectious anemia virus.. Arch Virol 1987;95(1-2):53-66.
              pubmed: 3036045doi: 10.1007/BF01311334google scholar: lookup
            17. Clabough DL, Gebhard D, Flaherty MT, Whetter LE, Perry ST, Coggins L, Fuller FJ. Immune-mediated thrombocytopenia in horses infected with equine infectious anemia virus.. J Virol 1991 Nov;65(11):6242-51.
              pubmed: 1717720doi: 10.1128/JVI.65.11.6242-6251.1991google scholar: lookup
            18. Coyne CP, Kelly AB, Hornof WJ, O'Brien TR, Philp MS, Lamb JF. Radiolabeling of equine platelets in plasma with 111In-(2-mercaptopyridine-N-oxide) and their in vivo survival.. Am J Vet Res 1987 Mar;48(3):385-91.
              pubmed: 3565893
            19. Zauli G, Re MC, Davis B, Sen L, Visani G, Gugliotta L, Furlini G, La Placa M. Impaired in vitro growth of purified (CD34+) hematopoietic progenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals.. Blood 1992 May 15;79(10):2680-7.
              pubmed: 1375110
            20. Murphy EA, Francis ME. The estimation of blood platelet survival. II. The multiple hit model.. Thromb Diath Haemorrh 1971;25(1):53-80.
              pubmed: 5577974
            21. McDonald TP, Cottrell M, Clift R. Effects of short-term hypoxia on platelet counts of mice.. Blood 1978 Jan;51(1):165-75.
              pubmed: 618555
            22. Swardson CJ, Kociba GJ, Perryman LE. Effects of equine infectious anemia virus on hematopoietic progenitors in vitro.. Am J Vet Res 1992 Jul;53(7):1176-9.
              pubmed: 1323227
            23. Walsh CM, Nardi MA, Karpatkin S. On the mechanism of thrombocytopenic purpura in sexually active homosexual men.. N Engl J Med 1984 Sep 6;311(10):635-9.
              pubmed: 6540841doi: 10.1056/NEJM198409063111004google scholar: lookup
            24. Wardrop KJ, Baszler TV, Reilich E, Crawford TB. A morphometric study of bone marrow megakaryocytes in foals infected with equine infectious anemia virus.. Vet Pathol 1996 Mar;33(2):222-7.
              pubmed: 8801716doi: 10.1177/030098589603300212google scholar: lookup
            25. Ballem PJ, Belzberg A, Devine DV, Lyster D, Spruston B, Chambers H, Doubroff P, Mikulash K. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection.. N Engl J Med 1992 Dec 17;327(25):1779-84.
              pubmed: 1435932doi: 10.1056/NEJM199212173272503google scholar: lookup
            26. Snyder EL, Moroff G, Simon T, Heaton A. Recommended methods for conducting radiolabeled platelet survival studies.. Transfusion 1986 Jan-Feb;26(1):37-42.
              pubmed: 3080829doi: 10.1046/j.1537-2995.1986.26186124029.xgoogle scholar: lookup
            27. Dassin E, Najean Y. The use of 75Se-methionine as a tracer of thrombocytopoiesis. I. In vivo incorporation of the tracer into platelet proteins: a biochemical study.. Acta Haematol 1979;61(2):61-7.
              pubmed: 154280doi: 10.1159/000207633google scholar: lookup

            Citations

            This article has been cited 13 times.
            1. Taylor SD, Leib SR, Wu W, Nelson R, Carpenter S, Mealey RH. Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiency. J Virol 2011 Jul;85(13):6814-8.
              doi: 10.1128/JVI.00077-11pubmed: 21543497google scholar: lookup
            2. Taylor SD, Leib SR, Carpenter S, Mealey RH. Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses. J Virol 2010 Jul;84(13):6536-48.
              doi: 10.1128/JVI.00218-10pubmed: 20392850google scholar: lookup
            3. Johns JL, Macnamara KC, Walker NJ, Winslow GM, Borjesson DL. Infection with Anaplasma phagocytophilum induces multilineage alterations in hematopoietic progenitor cells and peripheral blood cells. Infect Immun 2009 Sep;77(9):4070-80.
              doi: 10.1128/IAI.00570-09pubmed: 19564373google scholar: lookup
            4. Mealey RH, Littke MH, Leib SR, Davis WC, McGuire TC. Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: lack of correlation between in vitro activity and in vivo efficacy. Vet Immunol Immunopathol 2008 Jan 15;121(1-2):8-22.
              doi: 10.1016/j.vetimm.2007.07.011pubmed: 17727961google scholar: lookup
            5. Mealey RH, Sharif A, Ellis SA, Littke MH, Leib SR, McGuire TC. Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes. Virology 2005 Aug 15;339(1):110-26.
              doi: 10.1016/j.virol.2005.05.025pubmed: 15979679google scholar: lookup
            6. Mealey RH, Leib SR, Pownder SL, McGuire TC. Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection. J Virol 2004 Sep;78(17):9295-305.
              doi: 10.1128/JVI.78.17.9295-9305.2004pubmed: 15308724google scholar: lookup
            7. Mealey RH, Zhang B, Leib SR, Littke MH, McGuire TC. Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus. Virology 2003 Sep 1;313(2):537-52.
              doi: 10.1016/s0042-6822(03)00344-1pubmed: 12954220google scholar: lookup
            8. Mealey RH, Fraser DG, Oaks JL, Cantor GH, McGuire TC. Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses. Clin Immunol 2001 Nov;101(2):237-47.
              doi: 10.1006/clim.2001.5109pubmed: 11683583google scholar: lookup
            9. Harrold SM, Cook SJ, Cook RF, Rushlow KE, Issel CJ, Montelaro RC. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids. J Virol 2000 Apr;74(7):3112-21.
              doi: 10.1128/jvi.74.7.3112-3121.2000pubmed: 10708426google scholar: lookup
            10. Lonning SM, Zhang W, Leib SR, McGuire TC. Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors. J Virol 1999 Apr;73(4):2762-9.
              doi: 10.1128/JVI.73.4.2762-2769.1999pubmed: 10074123google scholar: lookup
            11. Zhang W, Lonning SM, McGuire TC. Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection. J Virol 1998 Dec;72(12):9612-20.
              doi: 10.1128/JVI.72.12.9612-9620.1998pubmed: 9811694google scholar: lookup
            12. Oaks JL, McGuire TC, Ulibarri C, Crawford TB. Equine infectious anemia virus is found in tissue macrophages during subclinical infection. J Virol 1998 Sep;72(9):7263-9.
              doi: 10.1128/JVI.72.9.7263-7269.1998pubmed: 9696821google scholar: lookup
            13. Sellon DC, Fuller FJ, McGuire TC. The immunopathogenesis of equine infectious anemia virus. Virus Res 1994 May;32(2):111-38.
              doi: 10.1016/0168-1702(94)90038-8pubmed: 8067050google scholar: lookup
            Subscribe to our newsletter
            Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.